0 XP   0   0   0

Imv Inc
Buy, Hold or Sell?

I guess you are interested in Imv Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Imv Inc

Let's start. I'm going to help you getting a better view of Imv Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Imv Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Imv Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Imv Inc. The closing price on 2022-09-30 was C$0.77 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Imv Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Imv Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Imv Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Imv Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -32,555.7% means that $-325.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Imv Inc:

  • The MRQ is -29,138.2%. The company is making a huge loss. -2
  • The TTM is -32,555.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-29,138.2%TTM-32,555.7%+3,417.4%
TTM-32,555.7%YOY-79,035.8%+46,480.1%
TTM-32,555.7%5Y-43,815.7%+11,260.0%
5Y-43,815.7%10Y-26,948.6%-16,867.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29,138.2%-242.4%-28,895.8%
TTM-32,555.7%-275.9%-32,279.8%
YOY-79,035.8%-342.1%-78,693.7%
5Y-43,815.7%-475.7%-43,340.0%
10Y-26,948.6%-561.7%-26,386.9%
1.1.2. Return on Assets

Shows how efficient Imv Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Imv Inc to the Biotechnology industry mean.
  • -23.7% Return on Assets means that Imv Inc generated $-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Imv Inc:

  • The MRQ is -24.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.5%TTM-23.7%-0.8%
TTM-23.7%YOY-17.2%-6.5%
TTM-23.7%5Y-23.0%-0.7%
5Y-23.0%10Y-26.0%+3.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.5%-9.7%-14.8%
TTM-23.7%-8.7%-15.0%
YOY-17.2%-9.2%-8.0%
5Y-23.0%-11.5%-11.5%
10Y-26.0%-12.4%-13.6%
1.1.3. Return on Equity

Shows how efficient Imv Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Imv Inc to the Biotechnology industry mean.
  • -410.2% Return on Equity means the company generated $-4.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Imv Inc:

  • The MRQ is -410.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -146.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-410.2%TTM-146.6%-263.6%
TTM-146.6%YOY-26.3%-120.3%
TTM-146.6%5Y-66.8%-79.8%
5Y-66.8%10Y-36.8%-30.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-410.2%-11.8%-398.4%
TTM-146.6%-11.1%-135.5%
YOY-26.3%-10.6%-15.7%
5Y-66.8%-13.5%-53.3%
10Y-36.8%-14.5%-22.3%

1.2. Operating Efficiency of Imv Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Imv Inc is operating .

  • Measures how much profit Imv Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Imv Inc to the Biotechnology industry mean.
  • An Operating Margin of -29,350.0% means the company generated $-293.50  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Imv Inc:

  • The MRQ is -29,350.0%. The company is operating very inefficient. -2
  • The TTM is -34,312.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-29,350.0%TTM-34,312.1%+4,962.1%
TTM-34,312.1%YOY-78,948.2%+44,636.1%
TTM-34,312.1%5Y-44,149.4%+9,837.3%
5Y-44,149.4%10Y-27,112.0%-17,037.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29,350.0%-232.1%-29,117.9%
TTM-34,312.1%-269.6%-34,042.5%
YOY-78,948.2%-309.3%-78,638.9%
5Y-44,149.4%-466.7%-43,682.7%
10Y-27,112.0%-572.5%-26,539.5%
1.2.2. Operating Ratio

Measures how efficient Imv Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 29,350.0% means that the operating costs are $293.50for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Imv Inc:

  • The MRQ is 293.500. The company is inefficient in keeping operating costs low. -1
  • The TTM is 320.050. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ293.500TTM320.050-26.550
TTM320.050YOY810.720-490.671
TTM320.0505Y562.588-242.538
5Y562.58810Y316.914+245.674
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ293.5003.321+290.179
TTM320.0503.542+316.508
YOY810.7203.491+807.229
5Y562.5885.744+556.844
10Y316.9147.007+309.907

1.3. Liquidity of Imv Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Imv Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 418.7% means the company has $4.19 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Imv Inc:

  • The MRQ is 4.187. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.560. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.187TTM4.560-0.373
TTM4.560YOY6.035-1.475
TTM4.5605Y5.604-1.044
5Y5.60410Y5.485+0.119
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1875.266-1.079
TTM4.5606.060-1.500
YOY6.0356.366-0.331
5Y5.6046.692-1.088
10Y5.4856.457-0.972
1.3.2. Quick Ratio

Measures if Imv Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 379.8% means the company can pay off $3.80 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Imv Inc:

  • The MRQ is 3.798. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.934. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.798TTM3.934-0.136
TTM3.934YOY5.288-1.355
TTM3.9345Y3.093+0.841
5Y3.09310Y1.903+1.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7984.055-0.257
TTM3.9344.865-0.931
YOY5.2885.192+0.096
5Y3.0935.275-2.182
10Y1.9034.997-3.094

1.4. Solvency of Imv Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Imv Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.94 means that Imv Inc assets are financed with 94.0% credit (debt) and the remaining percentage (100% - 94.0%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Imv Inc:

  • The MRQ is 0.940. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.641. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.940TTM0.641+0.300
TTM0.641YOY0.336+0.305
TTM0.6415Y0.544+0.096
5Y0.54410Y0.596-0.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9400.271+0.669
TTM0.6410.269+0.372
YOY0.3360.296+0.040
5Y0.5440.361+0.183
10Y0.5960.399+0.197
1.4.2. Debt to Equity Ratio

Measures if Imv Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 1,576.7% means that company has $15.77 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Imv Inc:

  • The MRQ is 15.767. The company is unable to pay all its debts with equity. -1
  • The TTM is 5.024. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ15.767TTM5.024+10.743
TTM5.024YOY0.513+4.511
TTM5.0245Y1.880+3.144
5Y1.88010Y1.035+0.845
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.7670.310+15.457
TTM5.0240.311+4.713
YOY0.5130.310+0.203
5Y1.8800.382+1.498
10Y1.0350.438+0.597

2. Market Valuation of Imv Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Imv Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -1.64 means the investor is paying $-1.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Imv Inc:

  • The EOD is -1.486. Company is losing money. -2
  • The MRQ is -1.640. Company is losing money. -2
  • The TTM is -3.182. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.486MRQ-1.640+0.154
MRQ-1.640TTM-3.182+1.543
TTM-3.182YOY-7.884+4.702
TTM-3.1825Y-7.260+4.078
5Y-7.26010Y-5.227-2.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.486-2.115+0.629
MRQ-1.640-2.332+0.692
TTM-3.182-3.889+0.707
YOY-7.884-5.087-2.797
5Y-7.260-3.697-3.563
10Y-5.227-3.390-1.837
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Imv Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Imv Inc:

  • The MRQ is -0.203. Very Bad. -2
  • The TTM is -0.139. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.203TTM-0.139-0.065
TTM-0.139YOY-0.144+0.006
TTM-0.1395Y0.139-0.278
5Y0.13910Y0.064+0.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2030.003-0.206
TTM-0.1390.019-0.158
YOY-0.1440.042-0.186
5Y0.1390.020+0.119
10Y0.0640.017+0.047

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Imv Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 28.96 means the investor is paying $28.96 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Imv Inc:

  • The EOD is 26.231. Seems overpriced? -1
  • The MRQ is 28.956. Seems overpriced? -1
  • The TTM is 13.193. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD26.231MRQ28.956-2.725
MRQ28.956TTM13.193+15.763
TTM13.193YOY8.655+4.538
TTM13.1935Y14.941-1.748
5Y14.94110Y31.868-16.927
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD26.2311.843+24.388
MRQ28.9561.961+26.995
TTM13.1932.789+10.404
YOY8.6553.538+5.117
5Y14.9412.782+12.159
10Y31.8682.419+29.449

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Imv Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.0290.208-86%0.499-94%0.342-91%0.223-87%
Book Value Per Share Growth---0.113-0.065-42%-0.018-84%-0.015-87%-0.006-95%
Current Ratio--4.1874.560-8%6.035-31%5.604-25%5.485-24%
Debt To Asset Ratio--0.9400.641+47%0.336+180%0.544+73%0.596+58%
Debt To Equity Ratio--15.7675.024+214%0.513+2973%1.880+739%1.035+1423%
Dividend Per Share----0%-0%-0%-0%
Eps---0.120-0.130+8%-0.1200%-0.128+6%-0.092-24%
Eps Growth--8.073-4.398+154%-2.399+130%29.779-73%10.867-26%
Gains Per Share---0.113-0.065-42%-0.018-84%-0.015-87%-0.006-95%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---291.382-325.557+12%-790.358+171%-438.157+50%-269.486-8%
Operating Margin---293.500-343.121+17%-789.482+169%-441.494+50%-271.120-8%
Operating Ratio--293.500320.050-8%810.720-64%562.588-48%316.914-7%
Pb Ratio26.231-10%28.95613.193+119%8.655+235%14.941+94%31.868-9%
Pe Ratio-1.486+9%-1.640-3.182+94%-7.884+381%-7.260+343%-5.227+219%
Peg Ratio---0.203-0.139-32%-0.144-29%0.139-246%0.064-417%
Price Per Share0.770-10%0.8501.573-46%4.173-80%3.619-77%2.139-60%
Quick Ratio--3.7983.934-3%5.288-28%3.093+23%1.903+100%
Return On Assets---0.245-0.237-3%-0.172-30%-0.230-6%-0.260+6%
Return On Equity---4.102-1.466-64%-0.263-94%-0.668-84%-0.368-91%
 EOD+2 -1MRQTTM+7 -11YOY+6 -125Y+7 -1110Y+6 -12

3.2. Fundamental Score

Let's check the fundamental score of Imv Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.486
Price to Book Ratio (EOD)Between0-126.231
Net Profit Margin (MRQ)Greater than0-291.382
Operating Margin (MRQ)Greater than0-293.500
Quick Ratio (MRQ)Greater than13.798
Current Ratio (MRQ)Greater than14.187
Debt to Asset Ratio (MRQ)Less than10.940
Debt to Equity Ratio (MRQ)Less than115.767
Return on Equity (MRQ)Greater than0.15-4.102
Return on Assets (MRQ)Greater than0.05-0.245
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Imv Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.347
Ma 20Greater thanMa 500.822
Ma 50Greater thanMa 1000.791
Ma 100Greater thanMa 2000.907
OpenGreater thanClose0.750
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets40,493
Total Liabilities38,078
Total Stockholder Equity2,415
 As reported
Total Liabilities 38,078
Total Stockholder Equity+ 2,415
Total Assets = 40,493

Assets

Total Assets40,493
Total Current Assets36,452
Long-term Assets36,452
Total Current Assets
Cash And Cash Equivalents 31,134
Net Receivables 1,938
Total Current Assets  (as reported)36,452
Total Current Assets  (calculated)33,072
+/- 3,380
Long-term Assets
Property Plant Equipment 4,041
Long-term Assets  (as reported)4,041
Long-term Assets  (calculated)4,041
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,707
Long-term Liabilities29,371
Total Stockholder Equity2,415
Total Current Liabilities
Short Long Term Debt 74
Accounts payable 8,255
Other Current Liabilities 94
Total Current Liabilities  (as reported)8,707
Total Current Liabilities  (calculated)8,423
+/- 284
Long-term Liabilities
Long term Debt Total 29,371
Long-term Liabilities  (as reported)29,371
Long-term Liabilities  (calculated)29,371
+/-0
Total Stockholder Equity
Common Stock156,329
Retained Earnings -175,335
Capital Surplus 12,915
Other Stockholders Equity 8,506
Total Stockholder Equity (as reported)2,415
Total Stockholder Equity (calculated)2,415
+/-0
Other
Capital Stock156,329
Cash And Equivalents31,134
Cash and Short Term Investments 31,134
Common Stock Shares Outstanding 82,269
Liabilities and Stockholders Equity 40,493
Net Invested Capital 30,627
Net Tangible Assets 2,415
Net Working Capital 27,745



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-30
> Total Assets 
636
606
604
607
604
595
611
814
10,536
9,891
9,048
7,721
13,795
12,713
11,550
9,267
7,748
7,142
8,266
6,847
5,476
3,850
3,960
2,495
2,535
5,096
3,730
3,319
14,045
12,448
10,658
8,918
7,392
5,952
4,803
10,976
9,116
15,101
13,537
21,501
18,880
17,032
26,904
30,547
26,213
22,925
42,395
37,345
30,329
22,434
15,329
41,402
67,975
58,800
39,392
33,172
49,563
50,121
40,833
40,493
40,49340,83350,12149,56333,17239,39258,80067,97541,40215,32922,43430,32937,34542,39522,92526,21330,54726,90417,03218,88021,50113,53715,1019,11610,9764,8035,9527,3928,91810,65812,44814,0453,3193,7305,0962,5352,4953,9603,8505,4766,8478,2667,1427,7489,26711,55012,71313,7957,7219,0489,89110,536814611595604607604606636
   > Total Current Assets 
636
606
604
607
604
595
611
814
9,762
9,139
8,296
6,956
13,050
11,989
10,731
8,468
6,973
6,383
7,531
6,139
4,790
3,194
3,330
1,892
1,960
4,549
3,194
2,802
13,551
11,965
10,136
8,397
6,868
5,447
4,307
10,496
8,831
14,785
13,192
20,925
18,275
16,469
26,243
28,322
23,271
20,042
39,515
34,282
27,357
19,604
12,587
38,577
65,142
55,961
37,163
30,590
46,223
46,390
36,661
36,452
36,45236,66146,39046,22330,59037,16355,96165,14238,57712,58719,60427,35734,28239,51520,04223,27128,32226,24316,46918,27520,92513,19214,7858,83110,4964,3075,4476,8688,39710,13611,96513,5512,8023,1944,5491,9601,8923,3303,1944,7906,1397,5316,3836,9738,46810,73111,98913,0506,9568,2969,1399,762814611595604607604606636
       Cash And Cash Equivalents 
632
599
604
607
603
593
584
528
1,079
7,777
6,866
5,718
11,657
10,413
9,299
7,504
4,205
5,071
6,497
5,079
3,645
2,002
2,475
893
1,139
3,536
2,047
1,706
12,500
10,662
8,557
6,925
5,339
3,842
2,082
8,926
7,908
13,547
11,774
19,273
16,595
14,909
24,019
25,148
20,271
14,895
34,207
26,904
21,374
14,066
7,372
28,251
54,700
46,362
30,453
22,826
36,495
38,616
28,689
31,134
31,13428,68938,61636,49522,82630,45346,36254,70028,2517,37214,06621,37426,90434,20714,89520,27125,14824,01914,90916,59519,27311,77413,5477,9088,9262,0823,8425,3396,9258,55710,66212,5001,7062,0473,5361,1398932,4752,0023,6455,0796,4975,0714,2057,5049,29910,41311,6575,7186,8667,7771,079528584593603607604599632
       Net Receivables 
4
7
0
0
1
1
2
4
8,611
1,178
1,067
1,024
1,166
1,288
1,161
766
2,314
1,009
777
851
886
892
679
869
708
842
907
852
872
1,038
1,229
1,193
1,262
1,378
1,988
1,352
506
769
921
910
1,003
722
1,163
1,432
1,577
2,448
2,334
3,035
2,308
2,506
2,539
2,353
3,251
3,954
2,217
2,589
1,862
1,737
2,448
1,938
1,9382,4481,7371,8622,5892,2173,9543,2512,3532,5392,5062,3083,0352,3342,4481,5771,4321,1637221,0039109217695061,3521,9881,3781,2621,1931,2291,0388728529078427088696798928868517771,0092,3147661,1611,2881,1661,0241,0671,1788,61142110074
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
350
373
571
541
669
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006695415713733500000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,880
3,063
2,972
2,830
2,742
2,825
2,833
2,839
2,229
2,582
3,340
3,731
4,172
4,041
4,0414,1723,7313,3402,5822,2292,8392,8332,8252,7422,8302,9723,0632,8800000000000000000000000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
327
322
331
354
345
333
438
427
413
407
393
375
363
343
327
309
291
274
272
262
249
249
294
300
310
298
296
285
286
236
345
576
605
563
662
2,225
2,942
2,883
2,880
3,063
2,972
2,830
2,742
2,825
2,833
2,839
2,229
2,582
3,340
3,731
4,172
4,041
4,0414,1723,7313,3402,5822,2292,8392,8332,8252,7422,8302,9723,0632,8802,8832,9422,22566256360557634523628628529629831030029424924926227227429130932734336337539340741342743833334535433132232700000000
       Intangible Assets 
0
0
0
0
0
0
0
0
447
430
421
411
401
391
382
372
362
352
342
333
323
313
303
293
284
274
264
254
0
235
228
221
214
207
201
195
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000195201207214221228235025426427428429330331332333334235236237238239140141142143044700000000
> Total Liabilities 
29
6
0
6
7
6
72
281
7,255
6,596
6,953
7,264
7,531
7,827
1,908
1,480
1,370
2,090
1,762
1,781
2,022
2,041
2,104
1,561
3,229
2,506
2,563
3,224
4,439
4,635
4,397
4,905
5,035
5,883
6,355
6,299
6,128
8,118
8,133
9,196
8,504
10,689
10,243
13,987
15,103
18,608
16,583
16,254
15,685
15,986
17,744
19,067
19,171
19,425
12,794
13,489
16,793
28,579
29,134
38,078
38,07829,13428,57916,79313,48912,79419,42519,17119,06717,74415,98615,68516,25416,58318,60815,10313,98710,24310,6898,5049,1968,1338,1186,1286,2996,3555,8835,0354,9054,3974,6354,4393,2242,5632,5063,2291,5612,1042,0412,0221,7811,7622,0901,3701,4801,9087,8277,5317,2646,9536,5967,255281726760629
   > Total Current Liabilities 
29
6
0
6
7
6
72
281
1,716
813
657
645
809
840
1,269
830
612
1,249
882
858
1,042
1,130
1,188
1,048
1,475
1,231
1,258
1,098
1,443
1,509
1,051
1,368
1,411
2,165
2,528
1,473
1,179
1,803
1,322
2,057
1,540
2,842
2,186
4,363
4,786
7,795
5,622
5,977
6,124
6,405
8,034
9,076
9,267
10,473
5,587
5,982
8,892
9,263
9,530
8,707
8,7079,5309,2638,8925,9825,58710,4739,2679,0768,0346,4056,1245,9775,6227,7954,7864,3632,1862,8421,5402,0571,3221,8031,1791,4732,5282,1651,4111,3681,0511,5091,4431,0981,2581,2311,4751,0481,1881,1301,0428588821,2496128301,2698408096456578131,716281726760629
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
6,393
6,647
60
61
75
93
92
81
84
86
87
88
0
0
0
1,094
0
0
0
0
0
0
0000001,094000888786848192937561606,6476,393430000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
6,393
6,647
60
61
75
93
92
81
84
86
87
88
342
592
843
1,094
868
78
76
73
75
74
74757376788681,094843592342888786848192937561606,6476,393430000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,302
1,243
1,973
1,460
1,684
2,094
4,248
4,565
5,282
5,383
5,733
5,876
3,665
7,525
8,286
8,236
4,757
4,606
5,785
8,557
4,628
8,815
8,255
8,2558,8154,6288,5575,7854,6064,7578,2368,2867,5253,6655,8765,7335,3835,2824,5654,2482,0941,6841,4601,9731,2431,3020000000000000000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
19
0
17
22
42
49
63
63
62
0
64
75
62
58
4,606
0
0
387
363
94
94363387004,6065862756406263634942221701927000000000000000000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,961
10,277
9,561
9,581
9,710
9,991
9,904
8,952
7,207
7,507
7,901
19,316
19,604
29,371
29,37119,60419,3167,9017,5077,2078,9529,9049,9919,7109,5819,56110,27710,9610000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,729
9,231
9,561
9,581
9,710
9,991
9,904
7,003
7,207
7,507
7,901
19,316
19,604
29,371
29,37119,60419,3167,9017,5077,2077,0039,9049,9919,7109,5819,5619,2319,7290000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167
476
549
619
1,371
1,260
1,292
1,584
1,436
1,232
1,046
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,0461,2321,4361,5841,2921,2601,3716195494761670000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,207
5,404
12,305
10,376
6,343
16,661
16,560
11,110
4,317
25,812
21,091
14,644
6,448
-2,415
22,335
48,804
39,375
26,598
19,683
32,770
21,542
11,699
2,415
2,41511,69921,54232,77019,68326,59839,37548,80422,335-2,4156,44814,64421,09125,8124,31711,11016,56016,6616,34310,37612,3055,4045,2070000000000000000000000000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,154
59,176
69,042
69,122
70,113
83,739
89,092
89,464
90,152
117,407
117,472
117,544
117,544
118,312
146,463
181,610
181,355
139,714
139,918
156,253
156,236
156,277
156,329
156,329156,277156,236156,253139,918139,714181,355181,610146,463118,312117,544117,544117,472117,40790,15289,46489,09283,73970,11369,12269,04259,17658,1540000000000000000000000000000000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000-2,043000-1,658000-1,149000-91000-800-779-763-843-825-808-785-767-751-736-717-702-687-672-653-634-615-596-572-547-524-502-475-453-452-4310000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,708
7,035
8,412
8,691
9,056
9,152
9,550
9,972
7,953
8,196
8,846
9,370
10,009
12,915
12,91510,0099,3708,8468,1967,9539,9729,5509,1529,0568,6918,4127,0356,7080000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
660
618
792
785
674
1,006
555
555
415
394
332
332
332
0
3,775
3,022
3,022
4,219
4,219
10,855
10,856
10,856
8,506
8,50610,85610,85610,8554,2194,2193,0223,0223,77503323323323944155555551,0066747857926186600000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue188
Cost of Revenue--
Gross Profit-188
 
Operating Income (+$)
Gross Profit-
Operating Expense-35,870
Operating Income-35,870-35,870
 
Operating Expense (+$)
Research Development23,080
Selling General Administrative16,020
Selling And Marketing Expenses-
Operating Expense35,87039,100
 
Net Interest Income (+$)
Interest Income188
Interest Expense-907
Net Interest Income-719-719
 
Pretax Income (+$)
Operating Income-35,870
Net Interest Income-719
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-36,589-35,870
EBIT - interestExpense = -40,007
-36,589
-35,682
Interest Expense907
Earnings Before Interest and Taxes (ebit)-39,100-35,682
Earnings Before Interest and Taxes (ebitda)-35,141
 
After tax Income (+$)
Income Before Tax-36,589
Tax Provision--
Net Income From Continuing Ops-36,589-36,589
Net Income-36,589
Net Income Applicable To Common Shares-36,589
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-3,230
Total Other Income/Expenses Net-719
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications